0000000000025272

AUTHOR

Orlando Guntinas-lichius

0000-0001-9671-0784

showing 11 related works from this author

Quality of life before and after total laryngectomy: Results of a multicenter prospective cohort study

2013

Background The purpose of this study was to determine what quality of life (QOL) areas improve and deteriorate during the first year after total laryngectomy and to identify predictors of these changes. Methods One hundred seventy-four patients completed the European Organization for Research and Treatment of Cancer (EORTC) QOL questionnaires before laryngectomy, n = 133 before discharge from hospital, n = 110 at the end of rehabilitation, and n = 86 1 year after laryngectomy. Multivariate regression analysis was performed to estimate the effect of potential predictors on QOL. Results Areas that did not recover to baseline level were physical functioning, role functioning, social functionin…

Longitudinal studymedicine.medical_specialtyRehabilitationbusiness.industrymedicine.medical_treatmentHead and neck cancermedicine.diseaseMental healthLaryngectomyOtorhinolaryngologyQuality of lifemedicineGlobal healthPhysical therapyProspective cohort studybusinessHead & Neck
researchProduct

The influence of nimodipine on chromatolysis of motoneurons following axotomy with and without reinnervation: A quantitative image analysis

1996

Using a recently developed image analysis method to quantify the time course of chromatolysis in injured motorneurons we tested the effect of the calcium entry blocker nimodipine (1000 ppm in food pellets) on regenerating and degenerating motoneurons. Following facial-facial, hypoglossal-hypoglossal anastomosis with complete regeneration and following facial and hypoglossal nerve resection which causes a partial neuronal degeneration and postoperative survival times of 4 to 112 days, the texture of the Nissl substance of facial and hypoglossal motoneurons was analyzed on both sides of the brainstem in paraffin serial sections with a VIDASplus image analyzer. Monitoring alterations of the Ni…

business.industryGeneral Neurosciencemedicine.medical_treatmentFacial nervesymbols.namesakemedicine.anatomical_structurenervous systemAnesthesiaChromatolysismedicineNissl bodysymbolsBrainstemAxotomybusinessNimodipineHypoglossal nervemedicine.drugReinnervationNeuroscience Research Communications
researchProduct

The use of texture analysis to study the time course of chromatolysis

1998

Image analysis of the textural feature entropy of the Nissl substance was used to monitor the time course of chromatolysis in regenerating hypoglossal motoneurons and degenerating facial motoneurons 4-112 days after hypoglossal-facial anastomosis in rats. Changes in the Nissl substance were detected that were not obvious on the basis of subjective judgement of the light-microscopical appearance of the neurons. Chromatolysis started 4 days post operation (dpo) and was not reversed at 112 dpo in both nuclei. The increase of chromatolysis was 14-28 dpo faster in the regenerating hypoglossal neurons than in degenerating facial neurons. Maximal chromatolysis was measured at 56-70 dpo in both nuc…

Hypoglossal NerveTime FactorsEntropyBiologysymbols.namesakeImage Processing Computer-AssistedmedicineAnimalsRats WistarMotor NeuronsGeneral NeuroscienceAnastomosis SurgicalAnatomyMotor neuronFacial nerveNerve RegenerationRatsFacial Nervemedicine.anatomical_structurenervous systemNissl BodiesChromatolysisTime courseNissl bodysymbolsFemaleNeuronNeuronal cell bodyNeuroscienceHypoglossal nerveJournal of Neuroscience Methods
researchProduct

Cetuximab, fluorouracil and cisplatin with or without docetaxel for patients with recurrent and/or metastatic squamous cell carcinoma of the head and…

2019

Abstract Background The combination of cisplatin, 5-fluorouracil (5-FU) and cetuximab (PFC) is the reference first-line treatment for recurrent/metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN). We analysed whether treatment intensification by the addition of docetaxel to PFC improved efficacy in R/M SCCHN. Methods A total of 180 patients with R/M SCCHN (1:1) were assigned to receive either cisplatin (40 mg/m2), docetaxel (40 mg/m2) and 5-FU (2000 mg/m2) at days 1 and 8 and cetuximab (400/250 mg/m2) at days 1, 8 and 15 (DPFC) or standard cisplatin (100 mg/m2) at day 1, 5-FU (1000 mg/m2) at days 1–4 and cetuximab (400/250 mg/m2) at days 1, 8 and 15 (PFC). Chemotherapy was…

0301 basic medicineOncologyAdultMaleCancer Researchmedicine.medical_specialtymedicine.medical_treatmentMedizinCetuximabDocetaxelDisease-Free SurvivalDrug Administration Schedule03 medical and health sciences0302 clinical medicineInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansProspective StudiesAgedCisplatinChemotherapyCetuximabbusiness.industrySquamous Cell Carcinoma of Head and NeckHead and neck cancerHazard ratioMiddle AgedInterim analysismedicine.disease030104 developmental biologyOncologyDocetaxelFluorouracil030220 oncology & carcinogenesisFemaleFluorouracilCisplatinbusinessmedicine.drug
researchProduct

Multicenter prospective study on the use and outcome of rehabilitation after total laryngectomy in Germany

2018

Background The purpose of this study was to assess the use and outcome of rehabilitation after total laryngectomy in Germany. Methods We enrolled patients who were scheduled for total laryngectomy, approached them again after surgery, after 3 months and 1 year. Patients completed questionnaires and were interviewed. Results Of 309 participants, 14% had not received any rehabilitation. Reasons for nonuse were primarily ongoing treatment and poor health. Users of rehabilitation had 4 times the odds of attaining any ability to speak compared to nonusers (odds ratio 3.8, P = .02). The main aim of rehabilitation from the perspective of the users was speech rehabilitation, mentioned by 71% before…

Malemedicine.medical_specialtyVoice Qualitymedicine.medical_treatmentLaryngectomySpeech TherapyOutcome (game theory)OddsCohort Studies03 medical and health sciences0302 clinical medicineQuality of lifeReference ValuesGermanySurveys and QuestionnairesmedicineHumansProspective Studies030223 otorhinolaryngologyProspective cohort studyLaryngeal NeoplasmsPostoperative CareRehabilitationbusiness.industrySpeech IntelligibilityOdds ratioSpeech rehabilitationPrognosisLaryngectomyTreatment OutcomeOtorhinolaryngologyPatient Satisfaction030220 oncology & carcinogenesisQuality of LifePhysical therapyFemaleLarynx ArtificialbusinessHead & Neck
researchProduct

Quality of life during the first year after partial laryngectomy: Longitudinal study

2018

This prospective study was conducted to assess changes in quality of life (QOL) of patients who undergo a partial laryngectomy.The European Organisation for Research and Treatment of Cancer Quality of Life Questionnaires Core and Head and Neck (EORTC-QLQ-C30, QLQ-HN35) were used preprocedure (n = 218), 1 week (n = 159), 3 months (n = 122), and 1 year after partial laryngectomy (n = 88). Changes over time were analyzed with the Wilcoxon signed rank test and the Holm-Bonferroni method, and interpreted regarding clinical relevance.Most subscales worsened 1 week postprocedure, but many recovered to baseline level after 1 year. Dyspnea and cognitive functioning deteriorated over time, with worst…

AdultMaleLongitudinal studymedicine.medical_specialtyTime FactorsLaryngectomy03 medical and health sciencesPostoperative Complications0302 clinical medicineQuality of lifeSurveys and QuestionnairesHumansMedicineLongitudinal StudiesProspective Studies030223 otorhinolaryngologyProspective cohort studyHead and neckLaryngeal NeoplasmsPartial laryngectomyAgedAged 80 and overbusiness.industryCarcinomaHead and neck cancersocial sciencesMiddle Agedmedicine.diseasehumanitiesOtorhinolaryngology030220 oncology & carcinogenesisQuality of LifePhysical therapyFemalebusinessHead & Neck
researchProduct

Cetuximab, fluorouracil (5-FU), cisplatin, and docetaxel as first-line treatment in patients with recurrent and/or metastatic squamous cell carcinoma…

2013

e17021 Background: This study investigates efficacy and toxicity of docetaxel added to cetuximab, cisplatin and 5-FU for patients with R/M SCCHN. We here report a planned second interim analysis to compare response rates between arms in order to decide on continuing to full accrual. Methods: Inclusion criteria were: stage III/IV R/M SCCHN and ECOG 0-1. Patients were randomized to arm A: cetuximab (standard dose) plus a maximum of 6 cycles of docetaxel (40 mg/m², day 1+8), cisplatin (40 mg/m², day 1+8) and 5-FU (2000 mg/m², day 1+8) or to arm B: cetuximab (standard dose), cisplatin (100 mg/m², day 1) and 5-FU (1000 mg/m², day 1-4). Treatment was administered until progression or intolerabil…

CisplatinOncologyCancer Researchmedicine.medical_specialtyCetuximabbusiness.industryInterim analysisClinical trialOncologyDocetaxelFluorouracilInternal medicineInterimToxicitymedicinebusinessmedicine.drugJournal of Clinical Oncology
researchProduct

Quantitative image analysis of the chromatolysis in rat facial and hypoglossal motoneurons following axotomy with and without reinnervation.

1996

Image analysis was used to quantify the time course of chromatolysis in regenerating and degenerating motoneurons. Following facial-facial, hypoglossal-hypoglossal nerve suture, or resection of facial and hypoglossal nerves with postoperative survival times of 4 h to 112 days, the texture of the Nissl substance of facial and hypoglossal motoneurons was analyzed on both sides of the brainstem in paraffin serial sections with a VIDASplus image analyzer. In this quantitative study of 149 Wistar rats, alterations of the Nissl substance were measured that were statistically significant but not yet visible to the human eye. Chromatolysis started significantly as early as 8 h and was not fully rev…

Hypoglossal NerveHistologyTime Factorsmedicine.medical_treatmentPathology and Forensic Medicinesymbols.namesakemedicineImage Processing Computer-AssistedAnimalsRats WistarMotor Neuronsbusiness.industryCell BiologyAnatomyFacial nerveAxonsNerve RegenerationRatsFacial Nervemedicine.anatomical_structurenervous systemNissl BodiesChromatolysisTime courseNerve DegenerationNissl bodysymbolsFemaleBrainstemAxotomybusinessHypoglossal nerveReinnervationCell and tissue research
researchProduct

Employment pathways and work-related issues in head and neck cancer survivors

2014

Background In this exploratory study, employment and psychological factors were investigated in head and neck cancer survivors with survivorship of ≥2 years. Methods Fifty-five head and neck cancer survivors ≤60 years old completed a survey including subscales from the Functional Assessment of Cancer Therapy (FACT) instrument, the Miller Behavioral Style Scale, the General Perceived Self-Efficacy Scale, the Patient Health Questionnaire-9 (PHQ-9), and the Hornheider–Fragebogen short version (HFB) measuring the need for psychological interventions. Exploratory analyses of associations to the employment status were performed. Results The rate of employed patients dropped from three-fourths of …

medicine.medical_specialtyCoping (psychology)business.industryHead and neck cancerPsychological interventionExploratory researchmedicine.diseaseWork relatedOtorhinolaryngologySurvivorship curvePhysical therapymedicineAnxietymedicine.symptombusinessPsychosocialClinical psychologyHead & Neck
researchProduct

Tobacco and alcohol consumption after total laryngectomy and survival: A German multicenter prospective cohort study

2016

Background We examined the relation of tobacco and alcohol consumption after total laryngectomy with overall survival (OS). Methods Tobacco and alcohol consumption was assessed at 5 time points after total laryngectomy. Patients were followed up for survival until December 31, 2014. A multivariate Cox regression was fitted to test for differences in OS. Results Three hundred fifty-nine patients were included in this study. Compared to former smokers, never smokers had hazard ratios (HRs) of 0.88 (95% confidence intervals [CIs] = 0.50–1.59), and continuous smokers 1.31 (95% CI = 0.87–1.96). Constantly high alcohol consumption after total laryngectomy had an HR of 2.19 (95% CI = 1.30–3.67). D…

medicine.medical_specialtyProportional hazards modelbusiness.industrymedicine.medical_treatmentHazard ratioConfidence intervalSurgeryLaryngectomy03 medical and health sciences0302 clinical medicineOtorhinolaryngology030220 oncology & carcinogenesisInternal medicineCohortmedicine030212 general & internal medicineRisk factorProspective cohort studybusinessCohort studyHead & Neck
researchProduct

Measuring quality of life in patients with head and neck cancer: Update of the EORTC QLQ-H&N Module, Phase III

2014

Background The objective of this study was to pilot test an updated version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Head and Neck Module (EORTC QLQ-H&N60). Methods Patients with head and neck cancer were asked to complete a list of 60 head and neck cancer-specific items comprising the updated EORTC head and neck module and the core questionnaire EORTC QLQ-C30. Debriefing interviews were conducted to identify any irrelevant items and confusing or upsetting wording. Results Interviews were performed with 330 patients from 17 countries, representing different head and neck cancer sites and treatments. Forty-one of the 60 items were retain…

medicine.medical_specialtyPsychometricsbusiness.industryDebriefingHead and neck cancerHead necksocial sciencesmedicine.diseasehumanitiesSurgeryOtorhinolaryngologyQuality of lifePhysical therapyMedicineIn patientPilot testbusinessHead and neckHead & Neck
researchProduct